Global University Venturing

The news roundup for the week ending 30 September 2016.

Cambridge Enterprise Seed Funds and Cambridge Innovation Capital have invested in Carrick Therapeutics, a company commercialising research from Cambridge and Oxford universities and Imperial College London.

KU Leuven's Centre for Drug Design and Discovery has closed a $67.5m commercialization fund with the support of the European Investment Fund.

GE Ventures and Allied Minds have established a strategic alliance to commercialise technologies from both partners' pipelines.

The gene sequencing technology developer has been spun out of Harvard University with $23m in series A capital provided by investors including Eli Lilly.

UC San Francisco spinout Fortis Therapeutics has closed an $18m series A round backed by Osage University Partners and an investment subsidiary of Eli Lilly.

The scheme, initiated in Stuttgart last year, will be replicated in Singapore in partnership with NUS Enterprise and Plug and Play.

Colorado University's Anschutz Medical Campus and UCHealth as well as Children's Hospital Colorado are set to benefit from an innovation hub that will support commercialisation efforts.

Jo Vanwittenbergh, marketing and business development manager at law firm NautaDutilh, offers eight tips to create an advisory board that is more than a pretty face.

Alphabet subsidiary Google Capital's participation in Airbnb's recently closed $850m round could presage advice on its newly formed innovation unit, as the company prepares to expand its offering.